MedPath

Effect of a drug (inj Clonidine) with Ropivacaine in a block for control of pain in breast surgery

Not yet recruiting
Conditions
Malignant neoplasm of breast of unspecified site, (2) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, (3) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2022/09/045531
Lead Sponsor
Department Of Anaesthesia RNT Medical College udaipur
Brief Summary

The purpose of this trial to find out minimum concentration of ropivacaine with clonidine for better Post operative analgesia in modified redical  mastectomy

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
78
Inclusion Criteria

Patients who are 18-60 year of age, ASA grade I and II, Normotensives or treated Hypertensives who will undergo MRM surgery will be included in the study.

Exclusion Criteria

Patient refusal,Patients with ASA III and higher,Patient having allergy to study drugs, Coagulation disorders,History of cardiovascular disease, Uncontrolled blood pressure,Pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DURATION OF ANALGESIAup to 24 hrs after completion of surgery
Secondary Outcome Measures
NameTimeMethod
THE RESCUE ANALGESIC REQUIREMENTOVER FIRST 24 HRS POSTOPERATIVELY

Trial Locations

Locations (1)

MB Govt. Hospital, RNT Medical College, UDAIPUR

🇮🇳

Udaipur, RAJASTHAN, India

MB Govt. Hospital, RNT Medical College, UDAIPUR
🇮🇳Udaipur, RAJASTHAN, India
Dr Amit Mittal
Principal investigator
9610070967
amitmttl60@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.